Michael Sukkar MP visits Trajan Headquarters

Michael Sukkar MP visits Trajan Headquarters

February 04, 2015

Trajan's global headquarters located in Ringwood, Melbourne, was visited by Michael Sukkar MP, Member for Deakin, Parliament of Australia on 4 February, 2015.

Mr Sukkar was pleased to tour a growing local advanced manufacturing facility, with Trajan exporting products used in scientific and medical analysis to customers in over 100 countries.

In the past, Trajan's SGE Analytical Science brand of chromatography consumables has been awarded an R&D100 Technology Innovation Award, Victorian Exporter of the Year and inducted into Victoria’s Manufacturing Hall of Fame.

Apart from the production of specialized components, Trajan also services the local Australian clinical and medical research sectors with a wide range of pathology consumables through its Grale HDS brand.

Mr Sukkar said it was a privilege to visit Trajan’s headquarters in Ringwood and hear the inspirational story behind this growing business.

“Stephen Tomisich and his team are at the forefront of analytical and medical science, developing and commercializing technologies that will make a real difference to the health and well-being of our nation,” he said.

“I look forward to visiting again soon and supporting this business as it continues to go from strength to strength.”

Chief Executive Officer of Trajan Stephen Tomisich said "It was a great opportunity to share our journey so far, and how we plan to contribute to a strong future of technology innovation and manufacturing in Australia."

Photo: Trajan's CEO Stephen Tomisich (right) explaining the critical features of an analytical syringe to Michael Sukkar MP (left).




Also in News

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More

European patent for Trajan’s hemaPEN
European patent for Trajan’s hemaPEN

July 13, 2020

Trajan Scientific and Medical is proud to advise that the European Patent Office will be granting a patent for hemaPEN® as a liquid collection device in Belgium, France, Germany, Ireland, Luxembourg, Monaco, Switzerland, Liechtenstein and the United Kingdom. Extensions are being sought across the remainder of Europe.

Read More

US FDA listing of Trajan’s hemaPEN blood microsampling device
US FDA listing of Trajan’s hemaPEN blood microsampling device

July 02, 2020

Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

Read More